These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 1863858)

  • 1. [From cholesterol to lipoprotein particle markers and/or risk factors].
    Fruchart JC; Cottet J
    Bull Acad Natl Med; 1991 Jan; 175(1):51-62; discussion 62-5. PubMed ID: 1863858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Triglyceride-rich lipoproteins as risk factors for atherosclerosis].
    Schwandt P
    Klin Wochenschr; 1990; 68 Suppl 22():54-8. PubMed ID: 2087080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoprotein immune complexes as markers of atherosclerosis.
    Orekhov AN; Kalenich OS; Tertov VV; Novikov ID
    Int J Tissue React; 1991; 13(5):233-6. PubMed ID: 1806545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Determination of the usefulness of selected biochemical parameters for assessing the advanced atheromatous changes in human coronary arteries].
    Bukowska H
    Ann Acad Med Stetin; 1998; 44():29-43. PubMed ID: 9857530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dyslipoproteinemia in patients with active rheumatoid arthritis: effects of disease activity, sex, and menopausal status on lipid profiles.
    Yoo WH
    J Rheumatol; 2004 Sep; 31(9):1746-53. PubMed ID: 15338494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma triglyceride-rich lipoprotein and high density lipoproteins disorders associated with atherosclerosis.
    Genest J; Cohn J
    J Investig Med; 1998 Oct; 46(8):351-8. PubMed ID: 9805418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein E genotypes and metabolic risk factors for coronary heart disease in middle-aged women.
    Cubrilo-Turek M; Stavljenić-Rukavina A; Sertić J; Zrinski R; Turek S; Grgac G; Ljubojević N
    Coll Antropol; 1998 Jun; 22(1):149-55. PubMed ID: 10097431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Determination of potentially atherogenic triglyceride-rich lipoprotein particles].
    Alaupovic P; Blankenhorn DH
    Klin Wochenschr; 1990; 68 Suppl 22():38-42. PubMed ID: 2087077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cholesterol bound to high density lipoproteins: critical review of the methods of analysis and personal data].
    Orso Giacone G
    Ann Osp Maria Vittoria Torino; 1982; 24(7-12):286-306. PubMed ID: 7137764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid Pentad Index: A novel bioindex for evaluation of lipid risk factors for atherosclerosis in young adolescents and children of premature coronary artery disease patients in India.
    Das B; Daga MK; Gupta SK
    Clin Biochem; 2007 Jan; 40(1-2):18-24. PubMed ID: 17052698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subendothelial retention of atherogenic lipoproteins in early atherosclerosis.
    Skålén K; Gustafsson M; Rydberg EK; Hultén LM; Wiklund O; Innerarity TL; Borén J
    Nature; 2002 Jun; 417(6890):750-4. PubMed ID: 12066187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-resistance and lipoprotein abnormalities.
    Fruchart JC
    Diabete Metab; 1991 May; 17(1 Pt 2):244-8. PubMed ID: 1936484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Metabolism and possible mechanisms of atherogenesis induced by lipoprotein (a)].
    Krempler F
    Wien Klin Wochenschr Suppl; 1984; 151():1-12. PubMed ID: 6091345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of the cardiovascular risk associated with atherosclerosis: HDL-cholesterol or apoproteins? (author's transl)].
    Haïat R; Bugugnani MJ
    Nouv Presse Med; 1982 Apr; 11(19):1487-9. PubMed ID: 6804931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel.
    Barter PJ; Ballantyne CM; Carmena R; Castro Cabezas M; Chapman MJ; Couture P; de Graaf J; Durrington PN; Faergeman O; Frohlich J; Furberg CD; Gagne C; Haffner SM; Humphries SE; Jungner I; Krauss RM; Kwiterovich P; Marcovina S; Packard CJ; Pearson TA; Reddy KS; Rosenson R; Sarrafzadegan N; Sniderman AD; Stalenhoef AF; Stein E; Talmud PJ; Tonkin AM; Walldius G; Williams KM
    J Intern Med; 2006 Mar; 259(3):247-58. PubMed ID: 16476102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated remnant-like particle cholesterol concentration: a characteristic feature of the atherogenic lipoprotein phenotype.
    Twickler TB; Dallinga-Thie GM; Cohn JS; Chapman MJ
    Circulation; 2004 Apr; 109(16):1918-25. PubMed ID: 15117861
    [No Abstract]   [Full Text] [Related]  

  • 17. [Lipoprotein(a): risk factor for atherosclerotic vascular disease important to take into account in practice].
    Couderc R; Maachi M
    Ann Biol Clin (Paris); 1999; 57(2):157-67. PubMed ID: 10210742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beyond low-density lipoprotein cholesterol: defining the role of low-density lipoprotein heterogeneity in coronary artery disease.
    Mudd JO; Borlaug BA; Johnston PV; Kral BG; Rouf R; Blumenthal RS; Kwiterovich PO
    J Am Coll Cardiol; 2007 Oct; 50(18):1735-41. PubMed ID: 17964036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Plasma concentration of lipoprotein(a) and distribution of its subtypes in the healthy population of Hungary].
    Császár A; Romics L; Lackner C; Dieplinger H; Karádi I; Utermann G
    Orv Hetil; 1990 Sep; 131(38):2071-5. PubMed ID: 2145542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The differences of serum cholesterol and lipoproteins in animals susceptible and nonsusceptible to atherosclerosis.
    Wang KQ; Li ZG; Hao QL; He JL; Li XZ; Zhang HZ; Tang JJ; Wu G; Chen BS; Wang JM
    Proc Chin Acad Med Sci Peking Union Med Coll; 1990; 5(2):112-9. PubMed ID: 2123036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.